International Journal of Radiation Oncology Biology Physics

publication venue for

Impact of Testosterone Recovery on Clinical Outcomes of Patients Treated with Salvage Radiotherapy and Androgen Suppression: A Secondary Analysis of the NRG/RTOG 0534 Sport Phase 3 Trial 2023
Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer 2023
Quality of Life Results of Addition of Androgen Deprivation Therapy and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy: NRG Oncology/RTOG 0534 SPPORT 2023
Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial 2022
Long-Term Toxicities of Adolescent and Young Adult Survivors of Cervix Cancer Who Underwent Radiation Therapy: A Cross-Sectional Analysis 2022
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes 2022
The Influence of Pelvic Lymph Node Dissection Volumes on Clinical Outcomes in NRG/RTOG 0534 2022
Comparison of Recurrence With High Retropharyngeal Nodal-Sparing Intensity-Modulated Radiation Therapy in HPV-Related and HPV-Unrelated Oropharyngeal Cancer 2021
Cost-Effectiveness of SABR in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-COMET Trial 2021
Creation of a National In-Training Examination in Radiation Oncology ― Impact Evaluation 2021
Does Tumor Response Correlate With Quality of Life Changes Following LU177 DOTATATE Therapy for Neuroendocrine Tumors? Observations From a Multicenter Prospective Study (NCT02743741) 2021
Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease 2021
OPAR: A Multicenter Phase II Randomized Trial of Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (APBI) 2021
Organ at Risk Dose Constraints in Stereotactic Ablative Radiotherapy: A Systematic Review of Active Clinical Trials 2021
Real-World Outcomes of Chemoradiation and Consolidative Durvalumab in Unresectable Stage III Non-Small-Cell Lung Cancer — A Systematic Review 2021
The Role of FDG-PET in Staging and Treatment for Stage III NSCLC in Ontario, Canada Between 2009-2017 2021
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial 2021
CCTG SC.24/TROG 17.06: A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases 2020
A Prospective Provincial PSMA-PET Registry for Recurrent Prostate Cancer: Preliminary results 2020
Canagliflozin Mediates Effective Blockade of the mTORC1 - HIF-1a Pathway, Inhibits Growth and Enhances Non-Small Cell Lung Cancer (NSCLC) Response to Radiotherapy (RT) 2020
Cardiac Morbidity Following Radical Thoracic Chemoradiotherapy for Locally Advanced Lung Cancer: A Population-Based Cohort Study 2020
Cardiac Toxicity in Central Non-Small Cell Lung Tumors treated with Stereotactic Body Radiation Therapy (SBRT) – Is there a “No-Flutter Zone”? 2020
Cost-Effectiveness of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) in the Treatment of Localized Renal Cell Carcinoma 2020
Does Sequencing of Adjuvant Therapy Influence Outcome for Stage IIIC Endometrial Carcinoma? A Multi-institutional Analysis 2020
Effect of Stereotactic Radiosurgery Compared to Whole-brain Radiotherapy for Limited Brain Metastasis on Long Term Cognition and Quality of Life: A Pooled Analysis of NCCTG N107C/CEC.3 and N0574 (Alliance) Randomized Clinical Trials 2020
Evaluation Of A Deep Learning-Based Auto-Segmentation Method For Quality Assurance Of Both Male And Female Pelvic Organ-At-Risk Contours In NCTN Clinical Trials 2020
Impact of Pelvic Intensity-modulated Radiotherapy (IMRT) on Lymph Node Coverage and Dose to Critical Organs, Compare to Three-Dimensional Conformal Radiation Therapy (3D-CRT), in Localized High-Risk Prostate Cancer 2020
Influence of Radiosurgery Dose on Pain Relief for Spinal Metastasis 2020
Local Control After Resection And Adjuvant Radiosurgery Compared To Radiosurgery Alone For Brain Metastasis: Exploratory Analysis Of Alliance NCCTG N107C 2020
Metastasis-Free Survival, but Not Biochemical Failure, is a Strong Surrogate Endpoint for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 2020
Optimizing the SPECT Imaging Workflow For Individualized Dosimetry in Lu177-DOTATATE Treatment Of Progressive Metastatic Neoendocrine Tumors 2020
Outcomes of Radiotherapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From The Canadian Kidney Cancer Information System (CKCis) 2020
Patient Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase II Study Evaluating 2 Ultrahypofractionated Regimens (UHR) for Prostate Cancer (CaP) 2020
Randomized Phase II Trial of Metformin in Combination with Chemoradiotherapy (CRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC); the OCOG-ALMERA trial (NCT02115464) 2020
Steep Dose-response Relationship between Maximum Hippocampal Dose and Memory Deficits following Hippocampal Avoidance Whole Brain Radiation Therapy (HA-WBRT) for Brain Metastases: A Secondary Analysis of NRG/RTOG 0933 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial 2020
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK) 2020
A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer 2020
A Comparison of Radiation Techniques in Patients Treated with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer 2019
Adjuvant Radiation for Endometrioid Adenocarcinoma Stage II (AREAS2): A Canadian Cohort 2019
DRIVE: Defining Radiorecurrent Intraprostatic Target Volumes 2019
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet 2019
Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3) 2019
Preliminary Results of a Two Stage Phase II Study of 18F-DCFPyL PET-MR for Enabling Oligometastases Ablative Therapy in Subclinical Prostate Cancer 2019
Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial 2019
Quantifying Renal And Tumor Doses with Individualized Dosimetry In 177Lu DOTATATE Therapy – What Difference Does It Make? 2019
Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) 2019
The Genomic Landscape of Anal Cancer and Its Relationship to Clinical Outcomes: An Exploratory Analysis of NRG Oncology/RTOG 98-11 2019
Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial 2018
Advanced Prostate Imaging of Recurrent Cancer after Radiation Therapy (PICs): Interim Results of a Prospective, Multi-Center Trial 2018
Can the Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) Predict Survival or Local Control in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC)? A Systematic Review 2018
Comparison of the Clinical Behaviour of N3 HPV Related and Unrelated Head and Neck Cancer in the IMRT Era 2018
Development of Best Practices of Peer Review in Lung Radiation Therapy 2018
Does Modern Mediastinal Irradiation Cause Acute Subclinical Cardiac Toxicity? The Final Results of the MEDICATE Study (Mediastinal Irradiation and Cardio-Toxic Effects) 2018
Identifying Potential Predictors of Late Renal Toxicity after Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Prospective Cohort Study 2018
Lung SBRT Credentialing in the Canadian LUSTRE Randomized Trial 2018
Lymph Node Ratio as a Predictor of Distant Metastases in Major Salivary Gland Carcinomas 2018
Outcomes of Stereotactic Body Radiation Therapy for Abdominopelvic Oligometastases 2018
Outcomes of Tri-Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer 2018
Patient-Reported Quality of Life Following Stereotactic Body Radiation Therapy for Primary Kidney Cancer: Results from a Prospective Cohort Study 2018
Renal SABR in Patients with a Solitary Kidney: An Individual-Patient Pooled Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK) 2018
Systematic Review of the Incidence of Chest Wall Toxicity Following Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer 2018
Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials 2018
A Phase 3, Multicenter, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy 2017
Comparison of Fiducial Marker Implantation and Soft Tissue Registration Using Cone Beam CT in Image-Guided Radiation Therapy of the Prostate 2017
Early Outcomes of Patients With Locally Advanced Esophageal Cancer Treated With Trimodality Treatments 2017
Identifying Barriers to Accrual in Radiation Oncology Randomized Trials: Insights From a Trial of Stereotactic Radiation for Oligometastatic Disease 2017
Improved Disease Control With Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: A Pooled Multi-institutional Analysis 2017
Individual Patient Data Meta-analysis of SBRT Kidney: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK) 2017
Long-Term Outcomes of Microinvasive Breast Cancer in the Canadian Hypofractionation Trial 2017
Neural Network-Based Range Verification for Proton Therapy Based on Prompt Gamma Emissions 2017
Prospective Longitudinal Assessment of Quality of Life and Symptoms in Patients With Oligometastatic Cancer Treated With Stereotactic Body Radiation Therapy: Analysis of a Phase 2 Trial 2017
Randomized Study of Quality of Life in Patients with High-Risk Prostate Cancer Undergoing Radiotherapy: Role of Pelvic Nodal IMRT 2017
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811 2017
N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease 2016
A Prospective Study Validating the EORTC QLQ–BM22 Bone Metastases Module in Patients With Painful Bone Metastases 2016
Brachytherapy for Endobronchial Metastasis: An Effective Method of Achieving Palliative Relief of Symptoms 2016
Current Practice of External Beam Radiation Therapy and Brachytherapy for Management of Endometrial Cancer in Ontario, Canada 2016
Enabling Conventional Cone Beam Computed Tomography With the Capability of Dual Energy Imaging Using a Simple Add-on Beam Modifier 2016
Failure of Standardized High-Dose Radiation (63 Gy/7 weeks) and 2 Cycles of Concurrent 5FU and Mitomycin to Control Large Anal Cancers 2016
Feasibility Study of Using Dual-Energy Cone Beam Computed Tomography (DE-CBCT) in Proton Therapy Treatment Planning 2016
Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning 2016
Minimal Clinically Important Differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL Modules in Patients With Bone Metastases 2016
NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results 2016
Stereotactic Body Radiation Therapy for Colorectal Liver Metastases—Long-Term Follow-up of a Single Center's Sequential Prospective Studies 2016
Systematic Review of Patient-Reported Quality of Life Following Stereotactic Ablative Body Radiation Therapy for Primary and Metastatic Liver Cancer 2016
Ten-Year Results of the Breast Intensity Modulated Radiation Therapy (IMRT) Randomized Controlled Trial 2016
The 21-Gene Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer Treated on SWOG S8814 2016
The Pathologic and Treatment Factors Associated With Recurrence in Stage IA Serous Adenocarcinoma of the Uterus 2016
Survival Benefit of Chemotherapy in Oropharyngeal Cancer Patients Treated With Surgery and Postoperative Radiation 2016
Dexamethasone Versus Placebo in the Prophylaxis of Radiation-induced Pain Flare Following Palliative Radiation Therapy for Bone Metastases: A Double-blind Randomized, Controlled, Superiority Trial 2016
NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer 2016
Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer 2016
Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA 2016
A Phase 2 Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-field Boost Radiation Therapy for Brain Oligometastases 2015
Ablative Therapy for Metastatic Breast Cancer: A Systematic Review 2015
Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer 2015
Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer 2015
Global Radiation Oncology Elective in Teaching CanMEDS Competencies 2015
High Dose Rate Brachytherapy: An Effective Treatment for Lower Gastrointestinal Malignancies 2015
Hyperfractionated Accelerated Reirradiation in Patients With Radiation Associated Secondary Angiosarcoma of the Breast: A Report of Local Control and Toxicity Using a Postoperative Radiation Therapy Approach 2015
Intraluminal Brachytherapy: An Effective Palliation for Cholangiocarcinoma Causing Bile Duct Obstruction? 2015
Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials 2015
Phase 2 Study of “0-7-21” Hypofractionated Palliative Radiation Therapy for Advanced Head and Neck Squamous Cell Carcinoma 2015
Photodynamic Therapy (PDT) With Porfimer Sodium Sensitizer Using HDR Planning Principles: A Single-Institution Experience of an Alternative Cancer Treatment 2015
Post–Biochemical Failure Risk Stratification to Predict Survival in Prostate Cancer: A Recursive Partitioning Analysis 2015
Quantifying the Targeting Accuracy of Liver Robotic Radiosurgery 2015
Radiation Therapy Quality of Care Indicators for Invasive Breast Cancer 2015
Survival in Patients With Brain Metastases From Non-Small Cell Lung Cancer Treated in the Radiosurgery Era 2015
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study 2015
Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126) 2014
First-Line Monotherapy With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Advanced Non-Small Cell Lung Cancer (NSCLC): Safety, Efficacy, and Correlation of Outcomes With PD-L1 Status 2014
Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced Non-Small Cell Lung Cancer (NSCLC) 2014
Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC) 2014
A Prospective Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy With High-Dose Heart Exposure 2014
A Prospective Comparative Analysis of 3 Methods of Rectal Retraction for High-Dose-Rate Brachytherapy in Cervical Carcinoma: Effect on Organs at Risk 2014
A Retrospective Review of Patient Outcomes Following High-Dose-Rate Brachytherapy in the Treatment of Cervical Cancer 2014
Adjuvant Radiation, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of RTOG 0621 2014
Best Practice in Advanced Esophageal Cancer: A Report on Trans-Tasman Radiation Oncology Group TROG 03.01 and NCIC CTG ES.2 Multinational Phase 3 Study in Advanced Esophageal Cancer (OC) Comparing Quality of Life (QOL) and Palliation of Dysphagia in Patients Treated With Radiation Therapy (RT) or Chemoradiation Therapy (CRT) 2014
Blinded Evaluation of Sinogram Affirmed Iterative Reconstruction in Radiation Therapy Planning Images 2014
Comparison of LDR Brachytherapy Versus External Beam Radiation Therapy for Low- And Intermediate-Risk Prostate Cancer: A Propensity-Score Matched Analysis 2014
Evaluation of Pseudoprogression in Patients With Glioblastoma (EPPIG) 2014
Head and Neck Squamous Cell Carcinoma of Unknown Primary: Is There a Better Treatment? 2014
Stereotactic Ablative Radiation Therapy Versus Low-Dose-Rate Brachytherapy: A Propensity Matched Analysis of Canadian Data 2014
Stereotactic Ablative Radiation Therapy for Gynecological Malignancies in the Oligometastatic Setting 2014
Stereotactic Radiosurgery for Refractory Trigeminal Neuralgia 2014
The Significance of p16 and p53 Expression on Clinical Outcome in Patients with Anal Cancer Treated with Chemoradiation Therapy: An Analysis of RTOG 98-11 2014
Tracheal Tumors Treated With Endotracheal Brachytherapy Alone: Experience From a Single Institution 2014
0-7-21 Hypofractionated Palliative Radiation Therapy in Advanced Head-and-Neck Cancers: A Retrospective Study 2014
Survival Outcomes of Early Stage Oral Cavity Squamous Cell Carcinoma: A Multi-institutional Analysis 2014
The Effects of Geography on Survival in Patients With Oral Cavity Squamous Cell Carcinoma 2014
A Preliminary Series of the Use of Stereotactic Radiosurgery (SBRT) in High-Risk Head-and-Neck Cancer 2013
A Randomized Controlled Trial of Lorazepam to Reduce Organ Motion in Patients Receiving Upper Abdominal Radiation Therapy 2013
Pulmonary Function Test and Its Predictive Factors in Patients With Lung Malignancies Treated With Stereotactic Radiation Therapy: A Retrospective Review From a Single Institution 2013
RTOG 0537 Phase 2/3 Study Comparing Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) Versus Pilocarpine (PC) in Treating Early Radiation-Induced Xerostomia (RIX): Phase 3 Preliminary Analysis 2013
Response and Quality of Life (QOL) Outcomes in a Randomized Trial of Single Versus Multiple Fractions (Fx) for Re-irradiation (RE-RT) of Painful Bone Metastases (PBM): NCIC CTG SC.20 2013
Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3D Conformal External Beam Radiation Therapy (3D CRT) 2013
A Phase II Study of Accelerated Hypofractionated 3-dimensional Conformal Radiation Therapy for Inoperable T1-3 N0 M0 Non-small Cell Lung Cancer: NCIC CTG BR.25 2012
Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury 2012
Cardiac Sparing With Breath-hold Technique: A Dosimetric Evaluation of Benefits in Different Patient Populations 2012
Development of a Patient Decision Aid for Older Women With Stage I Breast Cancer Considering Adjuvant Treatment Postlumpectomy 2012
Identifying Risk Factors for Locoregional Recurrence Following Postmastectomy Radiation Therapy 2012
Lung Cancer Disease Pathway Management Initiative: A Novel Approach to Provincial Quality Improvement 2012
Phase II Trial of Palliative Radiation Therapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases 2012
Radiological Diagnosis of Malignant Spinal Cord Compression — A More Favorable Entity? 2012
Referral of Suspected Lung Cancer by Family Physicians and Other Primary Care Providers: A Clinical Practice Guideline 2012
Retrospective Study of Hypofractionated Palliative Radiation Therapy for Advanced Head-and-Neck Cancers 0-7-21 2012
Tailoring Palliative Radiation Therapy (RT) Towards the End of Life — The Importance of ECOG Performance Status 2012
The Prostate Cancer Risk Stratification (ProCaRS) Project: Database Construction and Outcome Analysis 2012
The Prostate Cancer Risk Stratification (ProCaRS) Project: Recursive Partitioning Risk Stratification Analysis 2012
The Significance of Coexpression of Epidermal Growth Factor Receptor (EGFR) and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiation Therapy: An Analysis of RTOG 98-11 2012
Utilization of Radiation Therapy in Metastatic Castration Resistant Prostate Cancer Following the Introduction of Abiraterone into Clinical Oncology Practice 2012
Accumulated Delivered Dose-response of Stereotactic Body Radiotherapy (SBRT) for Liver Metastases 2011
An Ontario Clinical Oncology (OCOG) Randomized Trial (PET START) of FDG PET/CT in Stage 3 Non-small Cell Lung Cancer (NSCLC): Impact of PET on Survival 2011
Craniospinal Irradiation in Hematological Malignancies: Can the Helical Tomotherapy Become a Standard? 2011
Double-blinded, Placebo-controlled Randomized Study Evaluating the Efficacy of Risedronate to Prevent the Loss of Bone Mineral Density in Non-metastatic Prostate Cancer Patients Undergoing Radiotherapy Plus 2-3 Years of Androgen Ablation Therapy 2011
Electronic Web-based Technology Significantly Improves Quality of Life (QOL) Data Collection: Analysis of RTOG 0828 2011
Evaluation of Set-up Reproducibility with and without Customized Vacuum Immobilization Device in Rectal Cancer Patients Treated with Preoperative Pelvic Radiation Therapy 2011
Fractionated Stereotactic Radiosurgery with Concurrent Temozolomide for Locally Recurrent Glioblastoma Multiforme: A Prospective Study 2011
Outcomes of Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC) 2011
Prospective Evaluation of IMRT for Anal and Perianal Cancer: Early Patterns of Failure 2011
A Prospective Study of FDG-PET Imaging in Assessment of Response to Therapy in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplant 2010
Blocking Integrin Function Combined with Ionizing Radiation for Eradication of Bone Metastasis 2010
Changes in Liver Volume during Radiotherapy Delivered Concurrently with Sorafenib 2010
Evaluating the Dosimetric Impact of 3D vs. 2D Planning Techniques in Palliative Radiotherapy 2010
IMRT and Concurrent Chemotherapy for Anal and Perianal Cancer: The Princess Margaret Hospital Experience 2010
Imaging Sunitinib-induced Vascular Changes by DCE-MRI to Schedule Radiotherapy for Murine Renal Cell Carcinoma 2010
Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in Patients following Radical Prostatectomy (RP) with pT2-3, N0 Disease, and Elevated PSA Levels 2010
Low Dose Upper Abdominal Radiation Therapy (LD-UART) Potentiates Gemcitabine in Patients with Advanced, Unresectable Pancreatic Cancer (PC): Final Results from a Phase II Multi-Institutional Study 2010
Outcomes of Young Women with Ductal Carcinoma In Situ Treated with Breast-conserving Surgery and Radiotherapy: A Population-based Analysis 2010
RTOG 0537 Phase II/III Study Comparing Acupuncture-like Transcutaneous Electrical Nerve Stimulation (ALTENS) versus Pilocarpine in Treating Early Radiation-Induced Xerostomia (RIX): Phase II Results 2010
The Effects of Low Dose Hippocampal Radiation Exposure on Memory in Patients Receiving Stereotactic Radiosurgery for Benign Neurological Disorders 2010
Assessment of Cancer Pain Management using the Pain Management Index: A Canadian Multi-centered Investigation 2009
DELTA: A Randomized Trial of Decongestive Lymphatic Therapy for Women with Lymphedema following Treatment for Breast Cancer 2009
Determining Patterns of Therapy Choice in Patients Treated for Early Stage, Aggressive Histology Non-Hodgkin's Lymphoma 2009
LDR Prostate Brachytherapy: Dosimetric Evaluation of Stabilizing Needles and Seminal Vesicle Implants 2009
Outcomes of Adjuvant Intracavitary Brachytherapy Alone in Surgically Staged I/II, Grade 3 Endometrial Adenocarcinoma: The Cross Cancer Institute Experience from 1995 to 2006 2009
A Statistical Framework for the Assessment of Surrogates for Patient Setup Correction in Radiotherapy 2008
Adjuvant External Beam Radiotherapy in the Treatment of Endometrial Cancer: Results of the Randomized MRC ASTEC and NCIC CTG EN.5 Trials, A Systematic Review and Meta-analysis 2008
Cardiovascular Morbidity following Modern Treatment for Hodgkin Lymphoma: Age- and Sex- Specific Estimates of Risk in the Doxorubicin Era 2008
Influence of Gold Seed Implantation on Defining Target Volumes for Conformal Radiotherapy of Prostate Cancer 2008
Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer 2008
MRI-compatible Pneumatic Robot (MRBot) for Prostate Brachytherapy: Preclinical Assessment of Accuracy and Execution of Dosimetric Plans 2008
Radiation Therapy (RT) as a Chemopotentiator of Gemcitabine (G) in Patients with Advanced Pancreatic Cancer: A Multi-institutional Phase II Study 2008
Results of a Prospective Study on Brachytherapy in Lung Cancer in Combination with other Modalities 2008
Value of Chemotherapy with ECF in Advanced Esophageal Cancer Treated with Endoscopic Guided High Dose Rate Intraluminal Brachytherapy (EGHDRILBT) 2008
An Analysis of the Real Time Radiotherapy Review Process in an International Phase III Study: MA.20 2007
Association of Rectal Dosimetry and Toxicity With Body Mass Index After Permanent Brachytherapy for Low Risk Prostate Cancer 2007
Concurrent Pemetrexed/Cisplatin/Radiation for Unresectable Stage IIIA/B Non-Small Cell Lung Cancer: A Phase I/II Study 2007
Does the Addition of External Beam to HDR Intraluminal Brachytherapy, Improve Palliation of Esophageal Cancer: A Randomized International Multi-institutional Trial 2007
Monitoring Responses to Treatment With High-Frequency Ultrasound In Vivo: Assessing Response to Radiation vs. Photodynamic Therapy in Melanoma Xenograft Tumors 2007
Pain Flare Following Radiotherapy for Painful Bone Metastases: A Joint Effort of Three Cancer Centres to Determine the Incidence 2007
Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review 2007
The Needs of Newly Diagnosed Cancer Patients: Results of a Large Prospective Survey 2007
2132 2006
2160 2006
2177 2006
2406 2006
2413 2006
26 2006
The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation 2006
A Prospective Study to Evaluate the Need for an Immobilization Device for Treating Modified Mantle Fields in Lymphoma Patients 2005
Analysis of Gross Target Volume (GTV) Observer Variability with FDG-PET and Contrast Enhanced CT in Head and Neck Cancer Using Finite Element Modeling 2005
The Relationship of International Prostate Symptom Score with Urinary Flow Studies, and Catheterization Rates Following Iodine 125 Prostate Brachytherapy 2005
A randomized trial comparing a combination of iridium implant and external beam radiation to external beam radiation alone for patients with locally advanced prostate cancer 2004
Arm lymphedema in breast cancer patients: Is it always related to treatment 2004
Doppler optical coherence tomography for monitoring subsurface micro-structural and micro-vascular effects of cancer therapies 2004
Post radiotherapy biopsy correlation with PSA failure: Results from a randomized hypofractionated study in localized prostate cancer 2004
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathological complete response, local recurrence free survival &disease free survival 2004
Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone 2004
Sequential evaluation of prostate edema following permanent seed prostate brachytherapy using CT-MRI fusion 2004
Radiation therapy for Bowen's disease of the skin 2004
Review of eight years experience with the Rapid Response Radiotherapy Program at Toronto Sunnybrook regional cancer centre 2004
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin’s or Hodgkin’s lymphoma 2003
Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol 1999
99 The effects of radiation therapy on quality of life in women with breast cancer: Results of a randomized trial 1997
Is ipsilateral breast tumor recurrence an independent predictor of distant disease? 1993
Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas 1993
The value of transrectal ultrasound (TRUS) in the follow-up of endocavitary radiation (RT 50) treated rectal cancer 1993
A comparative study of late normal tissue effects in patients with multiple cutanedus tumours treated by single and multiple daily fractionation regimes 1981
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377.. 120:1461. 2024
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases Treatment.. S0360-3016(24)03641-1. 2024
A Randomized Trial of Hypofractionated Post-Mastectomy Radiation Therapy (PMRT) in Women with Breast Reconstruction (RT CHARM, Alliance A221505). 120:s11. 2024
Can Individualized Dosimetry Improve Treatment Efficacy for 177Lu-DOTATATE (D) Therapy in Primary Site Agnostic Neuroendocrine Tumors?. 120:e288. 2024
Chromosomal Instability as a Prognostic Biomarker for Local Failure in Laryngeal Carcinoma Patients Treated with Definitive Radiation in NRG/RTOG 9512. 120:s131-s132. 2024
Dosimetric Outcomes of SBRT to Ultracentral Lung Tumors: Lessons from the SUNSET Trial. 120:s106-s107. 2024
Forecasted Global Brachytherapy Shortfall by 2040: Investments Needed to Overcome this Deficit. 120:e754-e755. 2024
Geographical Disparities in Access to Radiotherapy in Brazil: An Observational Study. 120:e22-e23. 2024
International Harmonization of Technical Approaches to Kidney SABR – An International Radiosurgery Consortium of the Kidney (IROCK) Contouring Project. 120:e525. 2024
Kidney Cancer Patients' Treatment Preferences for Localized Disease. 120:e792. 2024
Outcome and Pattern of Failure Following Definitive High-Dose Radiotherapy for PrImary Vulvar CancEr: Interim Analysis of The DRIVE Multicenter Cohort Study. 120:s187-s188. 2024
Quality of Life in Patients Enrolled in a Randomized Clinical Trial Evaluating Hypofractionated Radiotherapy for Intermediate Risk Prostate Cancer. 120:s54-s55. 2024
Renal Function after Definitive Local Therapy for Primary Renal Cell Carcinoma: A Meta-Analysis. 120:s73-s74. 2024
Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for Unfavorable Intermediate and High-Risk Prostate Cancer; Early Results of PBS: A Phase II Randomized Trial (NCT03380806). 120:s126-s127. 2024
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer.. S0360-3016(24)03292-9. 2024
Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES). 119:1403-1412. 2024
Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma. 119:832-837. 2024
Proton Therapy Mediates Dose Reductions to Brain Structures Associated With Cognition in Children With Medulloblastoma. 119:200-207. 2024
Acute Toxicity Results from the Randomized Assessment of Cisplatin Dosing Interval for Ototoxicity (RADIO) Trial Comparing Chemoradiation (CRT) with Cisplatin Q3weekly to Weekly for Locally Advanced Squamous Cell Carcinoma of the Head and neck (LASCCHN). 118:e9-e9. 2024
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET). 120:669-677. 2024
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET). 118:e2-e2. 2024
5-Year Renal Function Outcomes after SABR for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK). 117:S84-S84. 2023
Circulating Growth Differentiation Factor 15 as a Biomarker in Patients with Unresected Locally Advanced Non-Small Cell Lung Cancer Treated with Chemo-Radiotherapy with or without Metformin. 117:e14-e15. 2023
Dose Reductions to Critical Brain Organs-at-Risk and Better Cognition in Children with Medulloblastoma Receiving Proton Therapy. 117:S134-S134. 2023
Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC). 117:e434-e434. 2023
Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER). 117:S82-S82. 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. 117:370-377. 2023
Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer. 117:S3-S4. 2023
Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer – A Secondary Analysis of the LUSTRE Randomized Trial. 117:S171-S171. 2023
Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy: Trial-Level Meta-Analysis and Individual-Level Analysis of NRG/RTOG 0617 and PROCLAIM. 117:S128-S128. 2023
Radiotherapy for Liver Cancer: An International Multi-Centre Pooled Analysis of 925 Cases. 117:e319-e320. 2023
Treatment Modalities to Manage Hepatocellular Carcinoma Patients with Portal Vein Thrombus: A Systematic Review and Meta-Analysis. 117:e319-e319. 2023
BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal Brachytherapy. 116:601-610. 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. 116:770-778. 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415. 116:39-49. 2023
In Response to Morgan et al. and Li et al.. 115:1012-1013. 2023
A Meta-Analysis of Trials of Partial Breast Irradiation. 115:60-72. 2023
LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC). 114:1061-1062. 2022
Definitive High-Dose Radiotherapy for Primary Vulvar Cancer: The DRIVE Multicenter Cohort Study. 114:S136-S137. 2022
Development of a Support Vector Machine-Based Tool for Survival Prediction after Stereotactic Body Radiotherapy for Liver Metastases Using Multi-Institutional Data. 114:e122-e122. 2022
First Pan-Canadian Consensus Recommendations for Proton Beam Therapy Access in Canada. 114:e343-e343. 2022
Long-Term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney). 114:S77-S77. 2022
Racial Disparities in Patients with Stage IIIC Endometrial Cancer. 114:e273-e274. 2022
Radiation Dose, Technique and Use of Brain Radiation on Overall Survival in Patients with Limited-Stage Small Cell Lung Cancer. 114:e411-e411. 2022
Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus?. 112:586-589. 2022
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126. 112:83-92. 2022
Evaluation of Long-Term Outcomes and Toxicity After Stereotactic Phosphorus-32–Based Intracavitary Brachytherapy in Patients With Cystic Craniopharyngioma. 111:773-784. 2021
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus (SPARTACUS): A Multicenter Prospective Trial Evaluating Acute Toxicities and Patient Reported Outcomes. 111:S18-S19. 2021
The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis. 111:S137-S138. 2021
Competency-Based Medical Education in Canadian Radiation Oncology Residency Training: An Institutional Implementation Pilot Study. 111:e21-e21. 2021
A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer. 110:1423-1431. 2021
Integrated Intraoperative MRI-Guided Brachytherapy for Cervical Cancer: An Institutional Experience of Treatment Workflow, Planning and Patient Toxicities. 108:e483-e484. 2020
Radiotherapy in Patients With Cardiovascular Implantable Electronic Devices: A Survey of Multi-Disciplinary Radiation Oncology Professionals. 108:e289-e290. 2020
Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic and Oligoprogressive Gynecologic Cancers: Clinical Outcomes of a Single Institution Analysis. 108:e179-e180. 2020
Stereotactic Radiotherapy for Oligoprogression in Metastatic Kidney Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Prospective Phase II Multi-Centre Study. 108:S27-S28. 2020
Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. 107:943-948. 2020
Erratum to: Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. Int J Radiat Oncol Biol Phys 2020;106:546-555.. 107:390-390. 2020
Erratum to: Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG II, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys 2020;106:255-260.. 106:1111-1111. 2020
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. 106:546-555. 2020
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). 106:255-260. 2020
Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows. 106:206-215. 2020
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial. 105:943-947. 2019
Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial. 105:165-173. 2019
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. 104:1057-1065. 2019
In a Heartbeat: An Assessment of Dynamic Dose Variation to Cardiac Structures Using Dual Source Computed Tomography. 102:950-959. 2018
Patterns of Failure Following Neoadjuvant SBRT or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer. 102:e69-e69. 2018
Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy (SBRT) for Resectable and Borderline Resectable (BLR) Pancreas Cancer. 102:S133-S133. 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. 102:287-295. 2018
Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases. 99:388-395. 2017
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate. 99:90-93. 2017
Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program. 98:521-529. 2017
Bioluminescence Tomography–Guided Radiation Therapy for Preclinical Research. 94:1144-1153. 2016
Changes in Liver Volume Observed Following Sorafenib and Liver Radiation Therapy. 94:729-737. 2016
Metabolic Tumor Volume Changes Measured by 18F-FDG-PET/CT After 1 Cycle of Induction Chemotherapy Is an Early Predictor of Radical Chemoradiation Therapy Outcome in Head and Neck Squamous Cell Carcinoma. 94:920-921. 2016
Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases. 93:639-648. 2015
Accuracy of Robotic Radiosurgical Liver Treatment Throughout the Respiratory Cycle. 93:916-924. 2015
Predictors of Adverse Cosmetic Outcome in the RAPID Trial: An Exploratory Analysis. 91:968-976. 2015
Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis. 91:505-516. 2015
Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis. 91:710-717. 2015
A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma. 90:369-375. 2014
Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma. 90:270-277. 2014
Randomized Trial of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord (RTOG 9512). 89:958-963. 2014
Individual Patient Data (IPD) Meta-Analysis of Randomized Controlled Trials (RCT) Comparing Stereotactic Radiosurgery Alone to SRS Plus Whole Brain Radiation Therapy in Patients With Brain Metastasis. 87:1187-1187. 2013
Memory Preservation With Conformal Avoidance of the Hippocampus During Whole-Brain Radiation Therapy for Patients With Brain Metastases: Primary Endpoint Results of RTOG 0933. 87:1186-1186. 2013
In Reply to Berrang et al. 87:633-633. 2013
A Population-Based Study of the Fractionation of Postlumpectomy Breast Radiation Therapy. 86:51-57. 2013
Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy. 85:1239-1245. 2013
A Prospective Study of the Utility of Magnetic Resonance Imaging in Determining Candidacy for Partial Breast Irradiation. 85:615-622. 2013
Phase II Trial of Radiosurgery to Magnetic Resonance Spectroscopy–Defined High-Risk Tumor Volumes in Patients With Glioblastoma Multiforme. 84:668-674. 2012
Development of Patients’ Decision Aid for Older Women With Stage I Breast Cancer Considering Radiotherapy After Lumpectomy. 84:30-38. 2012
Radiotherapy for Liver Metastases: A Review of Evidence. 82:1047-1057. 2012
Three-Year Outcomes of a Canadian Multicenter Study of Accelerated Partial Breast Irradiation Using Conformal Radiation Therapy. 81:1220-1227. 2011
Impact of Tumor Size and Volume on Outcomes following Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer. 81:S585-S585. 2011
Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis. 78:S56-S57. 2010
Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells. 78:221-229. 2010
A Phase III Randomized Trial of the Timing of Meloxicam With Iodine-125 Prostate Brachytherapy. 77:496-501. 2010
In Reply to Dr. Beal et al. 76:638-639. 2010
In Reply to Dr. Azria et al.. 75:1275-1276. 2009
Phase II Trial Combining Conventional Radiotherapy with Stereotactic Radiosurgery to High-risk Tumor Regions as Determined by MR Spectroscopy for Patients with Glioblastoma Multiforme. 75:S124-S124. 2009
Radiation-Induced Lymphocyte Apoptosis to Predict Radiation Therapy Late Toxicity in Prostate Cancer Patients. 74:1424-1430. 2009
Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO). 74:987-1001. 2009
Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial. 73:1069-1076. 2009
Comparison of Toxicity Associated With Early Morning Versus Late Afternoon Radiotherapy in Patients With Head-and-Neck Cancer: A Prospective Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). 73:166-172. 2009
Quantitative Ultrasound Characterization of Cancer Radiotherapy Effects In Vitro. 72:1236-1243. 2008
Role of Fractionated External Beam Radiotherapy in Hemangioblastoma of the Central Nervous System. 69:1521-1526. 2007
Ontario Radiation Oncology Residents’ Needs in the First Postgraduate Year-Residents’ Perspective Survey. 69:512-517. 2007
Intraobserver and Interobserver Variability in GTV Delineation on FDG-PET-CT Images of Head and Neck Cancers. 68:763-770. 2007
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A phase I-II study. 67:1027-1036. 2007
Computerized tomographic simulation compared with clinical mark-up in palliative radiotherapy: A prospective study. 65:824-829. 2006
Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography. 65:688-693. 2006
Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy. 65:358-363. 2006
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. 64:709-716. 2006
Radiation therapy for Bowen’s disease of the skin. 63:505-510. 2005
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. 63:37-46. 2005
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. 63:47-55. 2005
Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. 62:974-980. 2005
Two-dimensional mapping of underdosed areas using radiochromic film for patients undergoing total skin electron beam radiotherapy. 62:920-924. 2005
Penile brachytherapy: Results for 49 patients. 62:460-467. 2005
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status. 60:1127-1136. 2004
A randomized trial comparing a combination of iridium implant and external beam radiation to external beam radiation alone for patients with locally advanced prostate cancer. 60:S448-S448. 2004
Arm lymphedema in breast cancer patients: Is it always related to treatment. 60:S402-S402. 2004
Phase III evaluation of radiation with and without cetuximab for locoregionally advanced head and neck cancer. 60:S147-S148. 2004
Phase III evaluation of radiation with and without cetuximab for locoregionally advanced head and neck cancer. 60:S147-S148. 2004
Post radiotherapy biopsy correlation with PSA failure: Results from a randomized hypofractionated study in localized prostate cancer. 60:S171-S171. 2004
Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone. 60:S205-S205. 2004
Sequential evaluation of prostate edema following permanent seed prostate brachytherapy using CT-MRI fusion. 60:S456-S456. 2004
In regard to fortin et al., int j radiat oncol biol phys 2003;56:1013–1022. 58:1317-1318. 2004
Radiotherapy and the potential exploitation of bystander effects. 58:575-579. 2004
15-year results of total skin electron beam (TSEB) radiation as first-line monotherapy for newly diagnosed stage IA–IB mycosis fungoides (MF). 57:S291-S291. 2003
A Phase I–II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. 57:472-480. 2003
A randomized trial comparing two fractionation schedules for patients with localized prostate cancer. 57:S126-S126. 2003
In-vivo subsurface optical imaging of mycosis fungoides lesions prior to, during, and following radiation therapy. 57:S428-S428. 2003
Local superficial radiotherapy (LSRT) for newly diagnosed stage IA patch-plaque mycosis fungoides (MF) with only one, two or three presenting lesions. 57:S289-S290. 2003
Motexafin gadolinium (MGd) overcomes adverse survival effect of anemia in brain metastases (BM) patients treated with whole brain radiation therapy (WBRT): analysis of a phase III randomized trial. 57:S133-S133. 2003
Randomized prospective study comparing high dose rate intraluminal brachytherapy (HDRILBT) alone to HDRILBT and external beam radiotherapy (EBRT) in the palliation of advanced esophageal cancer. 57:S218-S219. 2003
A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases?. 55:565-567. 2003
Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus. 55:930-942. 2003
In response to Dr. Shakespeare. 55:850-850. 2003
Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. 55:594-605. 2003
Palliation of esophageal cancer: there is no clear winner. 55:849-850. 2003
Defining patient-based minimal clinically important effect sizes: a study in palliative radiotherapy for painful unresectable pelvic recurrences from rectal cancer. 54:661-669. 2002
Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). 54:719-728. 2002
Process and outcome of real-time radiotherapy review in a national study of prostate cancer radiotherapy. 54:276-277. 2002
Improving the consistency in cervical esophageal target volume definition by special training. 53:766-774. 2002
Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—an International Atomic Energy Agency study. 53:127-133. 2002
In regard to Denham et al., is it time for a new formalism to categorize normal tissue radiation injury? IJROBP 2001;50:1105–1106. 52:1147-1148. 2002
A prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an international atomic energy agency (IAEA) study. 51:264-264. 2001
Defining patient expressed minimal clinically important effect size (MCIES) for the relief of cancer pain. 51:52-52. 2001
Meta-analysis of single-fraction versus multi-fraction radiotherapy trials for palliation of painful bone metastases. 51:53-53. 2001
One year follow-up reveals no difference in quality of life between high dose and conventional dose radiation: a quality of life assessment of RTOG 94-05. 51:97-97. 2001
Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer; NCIC CTG SC.15. 51:20-20. 2001
The use of acupuncture-like transcutaneous nerve stimulation (CODETRON) in the treatment of radiation-induced xerostomia in head and neck cancer patients treated with radical radiotherapy. 51:411-411. 2001
Practice guideline on prophylactic cranial irradiation in small-cell lung cancer. 50:309-316. 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group.. 51:58-59. 2001
Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the radiation therapy oncology group protocol 91-04. 48:59-64. 2000
Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. 45:841-846. 1999
2190 Longer term follow-up of a prospective, randomized placebo controlled trial of concomitant chemotherapy and radiation vs radiation alone for advanced stage head and neck cancers. 45:375-376. 1999
Does Delay in Breast Irradiation Following Conservative Breast Surgery in Node-Negative Breast Cancer Patients Have an Impact on Risk of Recurrence?. 40:869-874. 1998
A randomized trial comparing combination of iridium implant and external beam radiation vs. external beam radiation alone in node negative locally advanced cancer of the prostate: Preliminary report. 42:302-302. 1998
Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. 40:447-453. 1998
Importance of the minimental status exam (MMSE) in the treatment of patients with brain metastases: A report from the radiation therapy oncology group protocol 9104. 42:261-261. 1998
Preparative regimens in bone marrow transplantation: An analysis of outcomes in 1174 patients. 42:194-194. 1998
A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the radiation therapy oncology group (RTOG) 9104. 39:571-574. 1997
Heterogeneity of polarographic oxygen tension measurements in cervix cancer: An evaluation of within and between tumor variability, probe position, and track depth. 39:405-412. 1997
Economic analyses. 38:907-908. 1997
2005 The effect of delay in initiating radiotherapy post-lumpectomy on local breast recurrence. 36:280-280. 1996
2022 Prognosis and management of oligodendrogliomas. 36:289-289. 1996
69 A randomized phase III study of accelerated hyperfractionation versus standard fractionation in patients with unresected brain metastasis: A report of radiation therapy oncology group (RTOG) 9104. 36:193-193. 1996
Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas. 33:985-991. 1995
In response to Drs. Yaes and Yu. 32:552-553. 1995
What influences the incidence of complications in esophageal cancer treated with telebrachytherapy? Response to Kumar et al., IJROBP 27:1069–1072; 1993. 32:277-277. 1995
Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.. 30:11-16. 1994
Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. 30:11-16. 1994
Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY. 28:839-845. 1994
Treatment of subdiaphragmatic Hodgkin's disease: Is radiotherapy alone appropriate only for inguino-femoral presentations?. 28:683-691. 1994
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. 28:355-362. 1994
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. 25:805-813. 1993
Medulloblastoma - Ontario provincial review (1977 – 1987). 27:263-263. 1993
Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. 22:853-858. 1992
Radiation therapy of esophageal cancer: Role of high dose rate brachytherapy. 22:1043-1046. 1992
Olfactory sensations produced by high-energy photon irradiation of the olfactory receptor mucosa in humans. 20:771-776. 1991
Optimal thoracic irradiation (TI) in the treatment of limited stage small cell lung cancer (LSCLC). 21:138-138. 1991
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable b-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. 18:909-920. 1990
Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. 18:783-786. 1990
In vivo optical properties of normal rat brain and application in photodynamic therapy. 19:259-259. 1990
A pilot study of whole body hyperthermia and local irradiation for advanced non-small cell lung cancer confined to the thorax. 15:427-431. 1988
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a canadian multicenter randomized trial. 14:219-226. 1988
Growth failure and other endocrine disorders following irradiation of childhood brain tumors. 13:88-88. 1987
Canadian multicentre randomized trial comparing two dose levels of thoracic radiation given in combination with chemotherapy to patients with limited small cell lung cancer. 12:157-157. 1986
Combining backscattered electrons and low energy photons to improve the dose distribution to an eyelid. 11:617-620. 1985
Upper half body irradiation (UHBI) for extensive small cell carcinoma of the lung. 9:1571-1574. 1983
Total skin electron irradiation for mycosis fungoides: Failure analysis and prognostic factors. 9:1279-1287. 1983
Upper half body irradiation (uhbi) for extensive small cell carcinoma of lung (SCCL). 7:1263-1263. 1981

International Journal of Radiation Oncology Biology Physics Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)